FP-025
- Generic Name
- FP-025
Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
- First Posted Date
- 2014-09-12
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02238834
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath